Essex Bio-Technology (HK:1061) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Essex Bio-Technology Limited has announced that its subsidiary has received approval to commercialize its preservative-free unit-dose Sodium Hyaluronate Eye Drops (0.3%) in the People’s Republic of China. The product is designed to treat a variety of ocular diseases and symptoms, providing a new preservative-free treatment option for conditions like dry eye syndrome. This marks a significant step for the company in expanding its portfolio of ophthalmic products in the Chinese market.
For further insights into HK:1061 stock, check out TipRanks’ Stock Analysis page.